Vaccination with a modified vaccinia virus Ankara (MVA)-vectored HIV-1 immunogen induces modest vector-specific T cell responses in human subjects

被引：17

作者：

Howles, Sarah ^{[1
]}

Guimaraes-Walker, Ana ^{[1
]}

Yang, Hongbing ^{[1
]}

Hancock, Gemma ^{[1
,2
]}

di Gleria, Katalin ^{[1
]}

Tarragona-Fiol, Tony ^{[3
]}

Hayes, Peter ^{[3
]}

Gilmour, Jill ^{[3
]}

Bridgeman, Anne ^{[1
]}

Hanke, Tomas ^{[1
]}

McMichael, Andrew ^{[1
,2
]}

Dorrell, Lucy ^{[1
,2
]}

机构：

[1] John Radcliffe Hosp, MRC Human Immunol Unit, Weatherall Inst Mol Med, Oxford OX3 9DS, England

[2] John Radcliffe Hosp, Oxford NIHR Biomed Res Ctr, Weatherall Inst Mol Med, Oxford OX3 9DS, England

[3] Univ London Imperial Coll Sci Technol & Med, IAVI Core Lab, Chelsea & Westminster Hosp, London SW10 9NH, England

来源：

VACCINE | 2010年 / 28卷 / 45期

基金：

英国医学研究理事会;

关键词：

HIV-1; vaccine; Modified vaccinia virus Ankara (MVA); T cell; Human; Clinical trial; THERAPEUTIC VACCINATION; ANTIRETROVIRAL THERAPY; TYPE-1; CLADE; EPITOPES; GAG; DNA; SMALLPOX; SAFETY; MVA; IMMUNODOMINANCE;

D O I：

10.1016/j.vaccine.2010.08.077

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

We investigated whether vaccination of healthy HIV-seronegative and HIV-1-seropositive antiretroviral therapy-treated subjects with recombinant modified vaccinia virus Ankara expressing an HIV-1 immunogen (MVA.HIVA) induced MVA-specific T cell responses. Using IFN-gamma Elispot assays, we observed new or increased responses to MVA virus in 52% of HIV-seronegative subjects and 93% HIV-1 seropositive subjects; MVA-specific T cell frequencies were generally low and correlated poorly with T cell responses to the HIV-1 immunogen. In two vaccinees, responses were mapped to CD8+ T cell epitopes present in replication-competent vaccinia virus. These data support further evaluation of MVA as a viral vector for HIV-1 immunogens. (C) 2010 Elsevier Ltd. All rights reserved.

引用

页码：7306 / 7312

页数：7

共 50 条

[21] Specificity and 6-Month Durability of Immune Responses Induced by DNA and Recombinant Modified Vaccinia Ankara Vaccines Expressing HIV-1 Virus-Like Particles [J].

Goepfert, Paul A. ;

Elizaga, Marnie L. ;

Seaton, Kelly ;

Tomaras, Georgia D. ;

Montefiori, David C. ;

Sato, Alicia ;

Hural, John ;

DeRosa, Stephen C. ;

Kalams, Spyros A. ;

McElrath, M. Juliana ;

Keefer, Michael C. ;

Baden, Lindsey R. ;

Lama, Javier R. ;

Sanchez, Jorge ;

Mulligan, Mark J. ;

Buchbinder, Susan P. ;

Hammer, Scott M. ;

Koblin, Beryl A. ;

Pensiero, Michael ;

Butler, Chris ;

Moss, Bernard ;

Robinson, Harriet L. .

JOURNAL OF INFECTIOUS DISEASES, 2014, 210 (01) :99-110

[22] Phase I clinical trial safety of DNA- and modified virus Ankara-vectored human immunodeficiency virus type 1 (HIV-1) vaccines administered alone and in a prime-boost regime to healthy HIV-1-uninfected volunteers [J].

Cebere, I ;

Dorrell, L ;

McShane, H ;

Simmons, A ;

McCormack, S ;

Schmidt, C ;

Smith, C ;

Brooks, M ;

Roberts, JE ;

Darwin, SC ;

Fast, PE ;

Conlon, C ;

Rowland-Jones, S ;

McMichael, AJ ;

Hanke, T .

VACCINE, 2006, 24 (04) :417-425

[23] Loading dendritic cells with PLA-p24 nanoparticles or MVA expressing HIV genes induces HIV-1-specific T cell responses [J].

Climent, Nuria ;

Munier, Severine ;

Pique, Nuria ;

Garcia, Felipe ;

Pavot, Vincent ;

Primard, Charlotte ;

Casanova, Victor ;

Maria Gatell, Jose ;

Verrier, Bernard ;

Gallart, Teresa .

VACCINE, 2014, 32 (47) :6266-6276

[24] Preferential Targeting of Conserved Gag Regions after Vaccination with a Heterologous DNA Prime-Modified Vaccinia Virus Ankara Boost HIV-1 Vaccine Regimen [J].

Bauer, Asli ;

Podola, Lilli ;

Mann, Philipp ;

Missanga, Marco ;

Haule, Antelmo ;

Sudi, Lwitiho ;

Nilsson, Charlotta ;

Kaluwa, Bahati ;

Lueer, Cornelia ;

Mwakatima, Maria ;

Munseri, Patricia J. ;

Maboko, Leonard ;

Robb, Merlin L. ;

Tovanabutra, Sodsai ;

Kijak, Gustavo ;

Marovich, Mary ;

McCormack, Sheena ;

Joseph, Sarah ;

Lyamuya, Eligius ;

Wahren, Britta ;

Sandstrom, Eric ;

Biberfeld, Gunnel ;

Hoelscher, Michael ;

Bakari, Muhammad ;

Kroidl, Arne ;

Geldmacher, Christof .

JOURNAL OF VIROLOGY, 2017, 91 (18)

[25] P18-04. MVA-nef vaccination induces specific T-cell responses exerting functions associated with non-progressive disease in HIV-1 infected individuals [J].

S Kutscher ;

S Allgayer ;

CJ Dembek ;

JR Bogner ;

FD Goebel ;

V Erfle ;

A Cosma .

Retrovirology, 6

[26] Transient IL-10 receptor blockade can enhance CD8+ T cell responses to a simian adenovirus-vectored HIV-1 conserved region immunogen [J].

Clutton, Genevieve ;

Bridgeman, Anne ;

Reyes-Sandoval, Arturo ;

Hanke, Tomas ;

Dorrell, Lucy .

HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2015, 11 (04) :1030-1035

[27] Recombinant influenza virus expressing HIV-1 p24 capsid protein induces mucosal HIV-specific CD8 T-cell responses [J].

Tan, Hyon-Xhi ;

Gilbertson, Brad P. ;

Jegaskanda, Sinthujan ;

Alcantara, Sheilajen ;

Amarasena, Thakshila ;

Stambas, John ;

McAuley, Julie L. ;

Kent, Stephen J. ;

De Rose, Robert .

VACCINE, 2016, 34 (09) :1172-1179

[28] MVA-nef induces HIV-1-specific polyfunctional and proliferative T-cell responses revealed by the combination of short- and long-term immune assays [J].

S Kutscher ;

S Allgayer ;

C J Dembek ;

J R Bogner ;

U Protzer ;

F D Goebel ;

V Erfle ;

A Cosma .

Gene Therapy, 2010, 17 :1372-1383

[29] Strong Human Endogenous Retrovirus-Specific T Cell Responses Are Associated with Control of HIV-1 in Chronic Infection [J].

SenGupta, Devi ;

Tandon, Ravi ;

Vieira, Raphaella G. S. ;

Ndhlovu, Lishomwa C. ;

Lown-Hecht, Rachel ;

Ormsby, Christopher E. ;

Loh, Liyen ;

Jones, R. Brad ;

Garrison, Keith E. ;

Martin, Jeffrey N. ;

York, Vanessa A. ;

Spotts, Gerald ;

Reyes-Teran, Gustavo ;

Ostrowski, Mario A. ;

Hecht, Frederick M. ;

Deeks, Steven G. ;

Nixon, Douglas F. .

JOURNAL OF VIROLOGY, 2011, 85 (14) :6977-6985

[30] Enhanced CD8+ T cell immune response against a V3 loop multi-epitope polypeptide (TAB13) of HIV-1 Env after priming with purified fusion protein and booster with modified vaccinia virus Ankara (MVA-TAB) recombinant:: a comparison of humoral and cellular immune responses with the vaccinia virus Western Reserve (WR) vector [J].

Gómez, CE ;

Rodríguez, D ;

Rodríguez, JR ;

Abaitua, F ;

Duarte, C ;

Esteban, M .

VACCINE, 2001, 20 (5-6) :961-971

← 1 2 3 4 5 →